Discussion page for Arch Therapeutics (ARTH)This page is for discussion of Arch Therapeutics (ARTH).
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
No ticker. Travis, if your reading. Someone suggested a board for Dr KSS who could review and forward any valid comments or questions so that Dr doesn’t get attacked by people when he says something they don’t like. I personally think that’s a good idea, I certainly hope Doc comes back and a buffer like that would prevent him from having to read hate mail.
Have a great weekend!
John
$ARCH still OW. Norchi may be a smart guy but why would a smart guy go out of his way to piss off his biggest and most important proponent? Dr KSS has single handedly boosted ARCH shares by touting the company, it’s CEO, and it’s science. Now, in accusing him of somehow influencing someone on this forum to seek out information (a RIDICULOUS accusation by the way), he has succeeded in causing his stock price to plummet after Doc has now pulled out which in turn has taken tens of thousands of shares out with him as members of the Gummune follow their leader. If I were Norchi, I would be scrambling to contact Doc and offer him the biggest apology he can muster in hopes of being brought back onto KSS good side.
I totally agree. Norchi must be under tremendous stress since the unexpected last-minute FDA questions. His FDA consultant should never have talked to Ron Oliver, but he can’t fire her because she is a big wheel in medical device regulation. So he made a boneheaded move. He should man up and apologize to DR KSS, even if Doc never recommends ARTH again.
John, he BETTER not fire her. When it comes to knowledge in the field of FDA submissions and navigating the waters of FDA protocols, Norchi and his company appear to need all the help they can get. The science may be great and I, like the Doc still believe in it. But belief and 3 bucks will buy you a cup of expensive coffee at Starbucks.
$ARTH currently ow with reduction inclination and intentions – DrBonZ, If Terry, Avtar and team, are willing to eat a bit of crow and bestow upon her the title or role of Chief Executioner Officer, COO, or similar, she may be able to right the ship and pull their fat out of the fire. #Best2YOUalwayz ~ Ben
I must be reading this wrong. Surely you are not suggesting Norchi should REWARD her for bad behavior?
I am indeed suggesting that she be promoted to a level with full authority to EXECUTE and pick up the pieces that these men left. They have repeatedly failed to produce a timely, transparent, favorable outcome.
I agree. Even though she violated nondisclosure and common sense, he can’t fire her. A painful bind for a CEO.
Maybe a letter from Gummune to Dr. Norchi pointing out lack of confidence and trust in him could make him realize his mistake and take a step back in accusing Dr. KSS – maybe they could even shake hands again in friendly manner after apologies.
I dunno if anything could reverse things that occurred – and mostly they shouldn’t get reversed- i’m just having hard time believing things turned so sour so quickly just because of a phone call that was very informative.
But i know it’s never harmful to try to clean places up after making a mess. Maybe there’s something beneath the surface of Arch Therapeutics that escapes a small-timer like myself and Arch Therapeutics will never execute the way many of us are still wishing, but if there’s hope left in the company it should be worth of trying to make difference.
$ARTH atlas OW
Another big drop today. For the first time ever, I am now in the red on ARTH.
same here DrBonz. i got in quite early too, but now i’m underwater with my shares. let’s hope for the best!
yours, Finn
Greetings DrB and FinV
(I suppose we don’t need to preface our comments with $ARTH here, do we.)
I’ve joined the $ARTH underwater crowd too. 🙁
I have a sell order in for about 1/4 of my holdings in each account, but since I’m doing FIFO, it will be the first-bought, lower-priced shares that will go, and my loss percentage for the remainder will look terrible. (That’s if the price rises to what I’ve asked for my selling price).
Remember, someone had to buy the 1.3 million shares traded today; they had faith.
Cheers,
Penny
Dunnydame, hang in there, i believe there are quite many of us Gummies feeling the way you do and the burden of crumbling share price right now.
I actually still believe there’s a lot to gain from Arch Therapeutics and that company’s not a scam, i have faith. Therefore i have no selling order in until share price reaches $1, probably won’t have even then. I’ve got no rush and will wait for at least this year and see what’ll happen. FIFO concept affects me too but now my whole position is under.
On the flip side i believe and acknowledge all Dr.KSS has said recently. I tend to think recent events will later be considered a kind of catalyst. Norchi’s not stupid, he knows what’s causing the share price to plunge and “feeling” the angry mob of investors. I hope this will make him understand that there’s a grave need for process – if there ever was intention to have any at first place – and they’ll change their course this year. One can delay milestones only so far before people start bailing out and that’s what’s happening right now. Takes time to earn trust, only a moment to loose it all.
yours, Finn.
Whew! Glad I’m not the only one. I’m in the red as well, having bought at .17, .40’s and some in the .60’s. I know much of where we are is due to the Dec. fumble but lately I think it’s the constant stream of exiting Gummies. For some strange reason, I simply can’t hit the sell button ! I’m sure it’s because I remain blown away by the science… and Cleveland’s confidence.
Finventurer – bad idea that anyone of us represent the Gummune to Dr. Norchi. Both Arth and Dr. KSS made it clear that random people should not be making contact with companies. Also, the universe of investors in Arth is larger than those active to the Gummune.
Reply from Rick Davis:
AC5 will need its own approval and we are working on achieving that goal.
Thanks and best regards,
Rick
Rick Davis
Chief Financial Officer
Arch Therapeutics, Inc.
235 Walnut Street
Suite 6
Framingham, MA 01702
(O) 617.431.2308
$ No ticker
Today’s market action
Needs application of AC5
$General tickers
Funny thing was, on our Schwab joint account earlier today, every single share was in the red on negative changes today 🙁 . Now, after the close, the only stock that’s green for a (very small) positive change is – wait for it – ARTH!
On my personal IRA account, of the 42 stocks there, just 7 are in the green for today’s changes (including $ARTH of course). Yup, bring on the AC5.
Cheers, Penny
$ARTH – sold half of my position today, unfortunately just below where I first bought it 2+ years ago. The rest is much more expensive and I still think the science looks good so I am holding onto these shares and hoping for a better result. I doubt it will be soon but biotech investing is full of pitfalls, this is just another one.
The fact this didn’t close red today is a good sign. I hope its the start of something positive. I know everything with the FDA takes so much time. IMMU said last summer they would have their application ready for the FDA by Q4 17 or early Q1 18, still no news that it has been submitted and its getting to be mid Q1 18.
I was lucky when I got in IMMU I only had to wait a year before anything ever moved that stock up, but some investors had been holding it for 10 years patiently waiting patiently watching management botch everything move. Hopefully luck hasn’t run out with Arth and it can gain some momentum. I got in last year, so I can hold through 2018 without giving up altogether on it.
$ARTH.. Allll righty people, anybody want to hazard a guess at a bottom for this thing? (other than .17).. Never thought I’d see the 20’s again. We’re close to 52 week low of .25.
$ARTH-half p;
Unfortunately I think this retest of the spike low was always on the cards…hopefully it will form a bottom around the .25 area and bounce back. But a lot of damage has been done on the charts and absent any major news it will be a slow grind from here.
$ARTH … I realize biotech investing is stomach churning but ARTH went from a Gummune star to a pariah with no new developments other than the recent unfortunate episode involving our esteemed Dr. KSS and TN. TN did not acquit himself well and should look in the mirror if he’s frustrated with ARTH’s progress (and share price). That being said, though I acknowledge there are some concerns about ARTH’s execution, the science hasn’t changed unless, of course, I missed something. I’m sticking with ARTH (for now) though I may need more antacid.
Antacid? Ah Man…..How ’bout a couple of shots of morphine….
No antacid; I’m breaking open my hoarded (dark) chocolate truffles.
Chocolate – knits up the ravell’d sleave of care, as the Bard might have said.
Penny – keeping her chin up.
What about the Curam involvement in ARTH research?
https://www.atlanticbridge.com/curam-centre-for-research-in-medical-devices-and-arch-therapeutics-execute-collaboration-agreement/
https://www.centerwatch.com/news-online/2016/09/29/backing-e68-million-curam-establishes-global-hub-medical-device/
$ARTH very ow and long
Earlier today I took advantage of the blue light special and topped off an already large position. I’m a very firm believer in the science and the company. In time, patience will be handsomely rewarded. I’ve copied and pasted from one of Cleveland’s fairly recent posts several of quotes from DrKSS regarding his convictions on the science of AC5. I am curious though why Cleveland has remained silent throughout the very tumultuous past week.
“I have a PhD in the molecular mechanisms of hemostasis and I KNOW it will work. ”
Arch’s “family of peptides are truly among the most remarkable biochemical inventions of all time.”
“Arch’s AC5, a aqueous hemostatic agent that may halve surgery times, reduce requirement for peri-operative blood transfusions, halt GI bleeding, shine for battlefield trauma, and even enable surgery without reverse anticoagulation for patients on blood thinners.”
“Still possibly one of the best medicine inventions of all time….a noncoagulant hemostatic agent.”
“I’ll declare it loud and clear: I have read many papers on the actions of AC5 and seen video footage of it being used in animal surgery, and it is the most impressive idea and product I have ever seen in 20 years of biotech investing.”
Cheers – Todd
I think though TN failed to get the 510(K) approved in Dec 2017, ARTH is in a better position to move forward. TN and his team had a learning experience. There are numerous accredited investors with money tied to this biotech. This may be an opportunity to load up the truck, similar to the early days when it was just starting with series A options priced at $0.25.
Here is Arth’s latest filing..
https://ir.archtherapeutics.com/all-sec-filings/content/0001144204-18-005155/0001144204-18-005155.pdf
Some things I pulled out of it, not sure I like what I see though!!
“…depending upon additional input from EU and US regulatory authorities, as well as the potential for more than one regulatory filing and approval in calendar year 2018, we may need to raise additional capital prior to the fourth quarter of Fiscal 2018.
“For example, on December 18, 2017, we announced that we voluntarily withdrew a 510(k) notice for AC5 Topical Gel from the FDA, with plans to submit a new 510(k) notice as soon as possible following further discussion with the FDA. In connection with those discussions, we will determine the most prudent path forward, which may include generating additional data and/or submitting additional documentation, and which could increase our cash needs.
“In addition, our estimates of the amount of cash necessary to operate our business may prove to be wrong and we could spend our available financial resources much faster than we currently expect. Further, our estimates regarding our use of cash could change if we encounter unanticipated difficulties or other issues arise, including without limitation those set forth under the heading “RISK FACTORS” in this filing, in which case our current funds may not be sufficient to operate our business for the period we expect.
Thoughts anyone??
Still have OW underwater position – who would have thought!!
$ARTH I agree. From the filing:
“…depending upon additional input from EU and US regulatory authorities, as well as the potential for more than one regulatory filing and approval in calendar year 2018, we may need to raise additional capital prior to the fourth quarter of Fiscal 2018.
“For example, on December 18, 2017, we announced that we voluntarily withdrew a 510(k) notice for AC5 Topical Gel from the FDA, with plans to submit a new 510(k) notice as soon as possible following further discussion with the FDA. In connection with those discussions, we will determine the most prudent path forward, which may include generating additional data and/or submitting additional documentation, and which could increase our cash needs.
“In addition, our estimates of the amount of cash necessary to operate our business may prove to be wrong and we could spend our available financial resources much faster than we currently expect. Further, our estimates regarding our use of cash could change if we encounter unanticipated difficulties or other issues arise, including without limitation those set forth under the heading “RISK FACTORS” in this filing, in which case our current funds may not be sufficient to operate our business for the period we expect”.
Perhaps there is more to this than an an easy question to answer, which needed more time as Norchi lead us to believe when he pulled the 510(K). I believe, as more time passes without a new application the stock will lose more value and be in more control of the day traders. Not a good situation. To me, all is in doubt now. Gonna stay clear until we know what is really going on, which may never happen with Norchi at the helm.
$ARTH
My major concern is how do you …”generate additional data” without additional trial?
The data required may have nothing to do with human trial results. “Arch still anticipates obtaining marketing clearance in 2018.”
Boilerplate written by lawyers. Nothing new.
Nothing new but they are going to need more cash to go beyond 2108. So if they don’t get there butts in gear gonna have to raise more cash. I’m surprised they haven’t made some statement to stop the freefall and give some encouragement to stock holders.
What statement would you make if you were Norchi?
First I would clarify what the FDA wants, and then elaborate how we plan to do that.
#suggested Norchi statement
And I would add that those plans include hiring the right people able to devote their time to getting this show on the road, so to speak.
TN does have Dr. Elaine Whitmore:
Elaine Whitmore, PhD
Regulatory Consultant, Advisor
Elaine Whitmore, PhD, brings over 25 years of extensive history in the medical products industry to Arch Therapeutics, with whom she started working in late 2010 focusing on regulatory planning and strategy. In addition to regulatory submissions, Dr. Whitmore’s experience includes development, testing, technology evaluation, and clinical planning for a variety of hemostasis products (fibrin sealants; bovine, human and recombinant thrombin products; cellulose; collagen; etc.), adhesion prevention products, and infection prevention products.
Dr. Whitmore is the author of Development of FDA-Regulated Medical Products—A Translational Approach (ASQ Quality Press, 2012) and has numerous patents for medical product technologies. Prior to becoming a product development and technology consultant, she held executive management industry positions in a variety of functions, including New Product Development, Regulatory and Clinical Affairs, Scientific Affairs, and Business Development. Dr. Whitmore received her PhD degree from Northwestern University.
https://play.google.com/store/books/details?id=OVi4eCga7RoC&source=productsearch&utm_source=HA_Desktop_US&utm_medium=SEM&utm_campaign=PLA&pcampaignid=MKTAD0930BO1&gclid=CjwKCAiAtdDTBRArEiwAPT4y-9ziW__Lm6yUaFHYswYRokMlg_qu2yPhsV2qMkBvjHL7PNW8Da4BRxoC0wsQAvD_BwE&gclsrc=aw.ds&dclid=CL_XuL2ViNkCFUbewAodzaYLcA
So you would reveal what the FDA wants before you have put together a response? I think that could be disastrous.
Or you would reveal your response before the FDA has signed off on it? That sounds foolish to me.
Sorry to be picky about this, but I don’t think people understand what the process is here, what is the best thing to do, and what EVERY OTHER company does in this situation.
$ARTH even more OW – bought more
You are implying that TN did not understand what exactly FDA wants. It is not hard to elaborate what his team plans to do to overcome those concerns. He already should have a plan with the concurrence of his team.
As TN withdrew 510(K) submission, FDA is not obliged to give anything in writing. It is like it never happened. Only TN knows what the FDA wants.
Thanks, this is a good discussion. All Norchi knows is what question the FDA had, and that he could not possibly prepare an answer in one day. He does not know exactly what the FDA wants to see to answer their question – that’s what the in-person meeting is for. He will present ARTH’s plan to proceed and get the FDA’s modifications and agreement. Then he has to wait for their written response because in the past there have been times the agency added or deleted things.
I don’t know if the FDA is legally obligated to schedule a meeting because they asked for more info on Day #89, but I would be shocked if they didn’t do it.
Is there an in-person meeting?
When?
I hope TN asked for it. or he already had one.
He should at least let us know. That would be nice.
Any guess what the FDA wants?
There has been some recent discussion along these lines. Of course, no one knows for certain, but educated guesses have been made. Search for “full thickness wounds” or similar, and I think you will find the right thread.
$ARTH,,, Guessing that past performance predicts future problems/possibilities.
Did manufacturing problems ever get resolved favorably?
FDA may need assurance that consistently quality of product is sure in commercial production.
Going from Lab to industrial production is often more difficult than first thought….
Perhaps Norchi needs trouble shooter liaison between himself and production facility?
What manufacturing problems?
archi: Do you mean the mixup about device and drug. That was a mistake by the manufacturer of the AC5. It is a device not a drug as far as I know.
AC5 is a device but still must be made or manufactured to meet specifications of quality such as safety, sterility, uniformity and effectiveness when used.
$ARTH Email Dr. KSS to see where he is hanging out privatekss@gmail.com
Reference to manufacture was about the application for CE mark in Europe that was delayed and failed though wrong records keeping and etc by the manufacture for AC5. We were sure CE mark was easy target bringing rewards 2 years ago in 2015. Now we are starting 3rd year with no real explanation .
If I am not mistaken Dr. KSS stated that he may take another look at $ARTH around July 2018.
That was not a manufacturing problem. The manufacturer filled out the drug approval form instead of the device approval form. But I do agree with you that Norchi owes us an explanation of when the C Mark application will be filed.
Failure to follow the Reagan Rule: ‘Trust BUT Verify”!
No matter what you choose to call it the problem still occurred at the manufacturing company. Had to be a failure of understanding of what was needed for compliance with rules/regulations. Wrong info on the packaging would still be wrong even if device was ok.
Regulation agencies are exacting and picky.
If an ordinary dummy like myself gets that it is hard to excuse some who is highly credentialed.
np – JohnM – that’s my only beef with Norchi, it has been over a year and not a word/timeline, nothing on C Mark.
#email DrKSS
Cleveland, please please tell me you aren’t seriously suggesting that we/someone email DrKSS? I respect his privacy, and in any case I wouldn’t dare, especially at this time of night.
Respectfully, Penny
This posted on Twitter..
KSS, MD, PhD
@KSSMDPhD
2h2 hours ago
To all biotech Gummies: I am still here for all, same as before. Travis has shut us down because he’s jealous of us. Let’s create a new beginning for ourselves on a website without maddening dysfunctional software where we can control things, Let’s give him something to resent.
TN failed CE mark for some very silly reason (manufacturers mistake about filling drug/device paper) and now failed 510(K) for another unexplained reason. Do we really know the truth?
How do I email DocKss ? About the new website ? Or contact Cleveland.
You can follow him on Twitter
Cleveland wrote: Email Dr. KSS to see where he is hanging out privatekss@gmail.com
Satydave, that has always been my fear with ARTH because they weren’t all that free with information, and over time, what they said didn’t match what was happening, and I’ve always wondered what it was I didn’t know. In the end, though, my conclusion has been that with such a small staff they just haven’t been able to accomplish things quickly and have been chronically overly optimistic about how long things will take. Some people are just that way. I’m not currently long ARTH, but do plan to get back in when funds are available and I like the price.
deleted
$arch who deleted toddba 2/3/18 message if KSS is not around?
This is Lynn’s thread.
Hindsight is always crystal clear.
The “esteemed, benevolent, well meaning….etc., etc., etc., good DrKSS” has played the majority of his followers here on the GS. During the holiday season he accumulated 30k+ of money and gift cards to help defray his costs of attending conferences and to compensate for his time and efforts on our behalf. I believe Cleveland stated the amount contributed was at least 10K beyond costs incurred in 2017 and the excess would go towards future expenses incurred. In several posts regarding the fund drive, KSS displayed almost an attitude of entitlement towards the gifting and seemed put off that the contributions were not larger. In his more gracious posts he was thankful and promised to e-mail each contributor and personally thank them. I’ll go out on a limb and guess that I am not the only who never received any response from KSS. What I did receive for the past few months was an immature child who displayed a faux outrage with various members who had made fairly benign posts that he purposely misinterpreted to sew confusion and panic amongst the herd. He held his breath, shook his little fists and took his toys and went home. Then he sat back and basked in the ridiculous renting of hair and gnashing of teeth among the community because their demi god had gone silent. Comical.
Good riddance to the petty man-child.
Cheers – Todd
Toddba you are a pethetic ungrateful individual who’s should walk the tracks
Well Todd, Dr KSS without remuneration helped a wonderful friend of mine with MDS gain access to the best medical treatment available in the world. He helped my friend enormously and without any remuneration or even a request for anything. He has helped me financially by shedding valuable knowledge of the science behind biotech stocks and I have profited enormously from his knowledge. So I’d say good by to you and hope you will stay here and not join us in our future endeavor.
No reason to devolve into a bickering match about Dr. KSS, so please cut that off here.
For those who might not have heard, Dr. KSS has decided to leave Stock Gumshoe and go off on his own. I haven’t heard from him regarding his plans, but he’s currently on Twitter @DrKSSMDPhD if you’d like to follow him or follow up with him. I wish him well.
You are a gentleman, Travis.
Cheers – Todd
I am sure Dr KSS will be able to put together a website that is better tailored to his desires if the amount of donations he recently received is anything to go by. While I won’t be joining and will pull back from much biotech investing (I have proved I am not a proficient trader!) I remain very grateful for Travis’s sleuthing, for the courteous atmosphere he has created, and the ability to discuss stocks amicably with gummy friends. I raise a glass to everyone’s successful investing going forward.
No ticker; Classy post Sharon!
Regards,
Frank
ditto to that,,,
Well said. I’d add that I was ‘sleuthing’ on my own when I stumbled onto Travis site 8 or more years ago, and have enjoyed his many posts over the years. I only realized how much I was missing by not being an irregular 6 months or so back. I had only been on Doc’s thread a month and a half and enjoyed reading and learning.
Hey Sharon – I hope you plan to stick around SG. With help from Travis and other Gummies we should (?) become better traders/investors, biotech or otherwise.
Penny
Oh yes, I’ll be here, Dunnydame. I love the adventure of trying to see where markets may be headed and finding the next Apple or Amazon.
You are showing your true colors!
Most brilliant people are a bit highly strung, that needs to be taken into account. No one is 100% perfect but you are the one who is behaving childishly. The Doc’s gifts weigh far more heavily than any of his supposedly minor defects.
Most Gummies appreciate that. You are an obvious exception!
Travis do you have a rebuttal? I find it hard to believe you shut KSS down?
Inquiring minds need to know! Plus details leading to the theatrics.
Unitedshareholders had the same dramatics x10.
Rumrunner. Did you join the Stock Gummshoe Community? It is run, and I believe owned, by Travis Johnson. Dr. “KSS” was a guest as well.
I joined Mr. Johnson’s group for obvious reasons, and they didn’t include gossip, manipulation, deceit, or whatever word you find offensive. It worked out well for a while, but people being people, some think of it as their own sight.
I am sure Travis made a business decision, and since it is his business, I abide by it, and don’t feel privvy to his why’s or why not’s.
Per KSS’s tweet, Travis shut him down and then KSS proceeded to burn the bridge in the same tweet
I am not privy but think the gossip and deceit would be entertaining.
Relax and enjoy the show.
It could be entertaining, tiresome, or best served on another sight. It is hard enough trying to keep up with all of the different posts within Stock Gumshoe.
Let this sight remain dedicated to it’s cause. There is enough drama going on all around you.
There is a reason that people are quiet in a library. That is why someone else decided to create a Sports Bar in another building.
Just my thoughts…………….
#email DrKSS
Well, after ploughing/plowing my way through today’s crop of messages, I understand why Cleveland gave out Dr KSS’s e-mail address – it wasn’t some sort of aberrant behavior on Cleveland’s part.
My mind is still reeling and I’m waiting for the dust to settle as it will eventually.
Penny
#AllenFrances – My 40 yrs experience condensed into 12 tips to ensure safe/accurate diagnosis.
From ‘Essentials of Psychiatric Diagnosis’ https://twitter.com/AllenFrancesMD/status/959775436061384704
Nobody knows yet what Amazon, Berkshire Hathaway, and JPMorgan have planned for their new healthcare venture. @matthewherper explains the speculations out there, and the challenges: https://twitter.com/forbeshealth/status/959505578056962049
Toddba I might sure you benefit in any way us from the doc so for you to write what you did just shows you have a junenile mind. You don’t walk in the docs shoes and couldn’t put possibly know how people like you make him feel. When you open your mouth your ignorance shows
If anyone is pathetic its motordoc . You made your point in the previous entry. Why hammer Todd again?
I reread KSS responses several times and found them bazarre and inexplicable.
You’re certainly entitled to your opinion, motordoc. I understand that many in the forum hold KSS in very high esteem and depend upon him for financial guidance. And for theses reasons I kept my feelings regarding KSS to myself. When he abruptly abandoned the forum on completely false pretenses and saw fit to attack the website’s owner, I allowed myself the indulgence of pettiness. No regrets though.
Good luck to you and yours. – Todd
Toddba after reading more posts I’m not or sure what to think about the situation if it turn out I was wrong I opologize
Accepted, although not necessary. I don’t take anything written by someone who truly doesn’t know me personally. Communication is a very tenuous affair even when conducted face to face. And this is the reason I do not participate in any form of social media other than this forum.
Cheers – Todd
RE: #KSS, If you don’t have a twitter account here is a relevant post from last evening from Dr. KSS:
“To all biotech Gummies: I am still here for all, same as before. Travis has shut us down because he’s jealous of us. Let’s create a new beginning for ourselves on a website without maddening dysfunctional software where we can control things, Let’s give him something to resent”.
Blaming your employer imo is like Norchi blaming his share holders when things aren’t going well.
Some have commented elsewhere that Dr. KSS has anger problems, has lost his medical license and more, which I am not being judgemental about, however I think if you were to do due diligence by looking at his “other self” under his real name, you might be kinder to people like Toddba who have questioned his motives or integrity. In my opinion there are times when his judgement has been very poor. In my personal journey, I feel like someone who has “freed myself” from the attachment to him and his suggestions, at a vast financial loss, but am glad this charade is over.
Let’s make it simple Dr Kss is an eccentric genius
#KSS, Ron could you be so kind as to tell me KSS real name. I did try doing my own DD and there was a posting on the internet with a picture identifying this person as DRKSS. Did not know if it was accurate.
Long time member of SG and have read with interest and invested in several of the bio stocks. Over the 3 years I have probably broke even. Best wishes to all the Gummies. Go outside and enjoy the weekend.
Karen
$Going Forward – just some thoughts and a couple of suggestions.
1. Whatever the reason for their breakup, I support both Travis and DR KSS. I will remain an SG Irregular for Travis’ work, and join whatever new venture Doc creates.
2. Can we maintain the discussion on three threads going forward?
A. This thread can be for ARTH-related posts.
B. There was a “Going Forward Without DR KSS” thread that I think GR8FULL! started. If we can find it or restart it, that could be for all other biotech stocks.
C. The third one would be the excellent BIOTECH/MEDICAL CATALYST CALENDER at
https://www.stockgumshoe.com/2015/04/microblog-biotechmedical-catalyst-calender/, also started by GR8FULL.
This way we will not lose our collective DD momentum until KSS has his newsletter started. He has given us lots of recent ideas to work on. What say ye?
Love the idea of the three threads. I don’t post much but I encourage all Gummies to explore the stockgumshoe site. There is a considerable amount of excellent research here and Travis provides his portfolio with detailed trades.
Probably won’t follow Doc as I have just retired at 57 and honestly don’t need the drama.
An excellent idea, JohnM.
JohnM Certainly is a most logical course. Anyone can ask for a new thread at any time and Travis very graciously will provide.
As needed in future.
Yes, JohnM, if the momentum is to continue, we’re it. I hope some of the stellar contributors will stay with us.
Question: Is someone still keeping up that wonderful, fabulous, indispensable multi-page spreadsheet that shows the progression of thought on various stocks over time? OpposableThumb?
KSS IS DA MAN https://docs.google.com/spreadsheets/d/1tyFFLmr6QymjbC5JS95V4wqdQl-Sw11nIGEuf0u_sjs/edit#gid=695118274
As I like the biotech area (has no bearing on how successful I am!), I intend to follow Dr KSS still, provided that his new service, whenever it gets established, doesn’t price me out.
Thought: How easy it is going to be balancing what we discuss here, with what is discussed there, without treading on proprietary toes?
Cheers, Penny (lifetime Irregular)
Very insightful Penny. To quote Winston Churchill,, ” It is a riddle, wrapped in a mystery, inside an enigma” In other words you have a very good point. We want to continue this because we have made friends and gained a lot of insight from so many people. So sad if it were to end.
I don’t know if any of you have followed the George Webb posts or some of the Qanon youtube videos, but I have been exploring some of them. Some of the news lately has intrigued me with the juxtaposition of the importance of what is happening and the utter absence of interest in the MSM. (Mainstream media). Unless you are searching on the internet you will likely not have heard of the stunning amount of arrests taking place that are related to pedophilia and human trafficking.
While I was searching for developments ‘not’ covered by the MSM, I came across the video of a man who is one of the most compelling witnesses I have seen about the corruption that has been infecting our country. He was one of the FBI heads (of a district) and an able and, in my opinion, honest investigator. I think what he has to say after decades of research is well worth watching. Part of what he shared had me wondering about the train with the Republicans hitting a garbage truck whose drivers did not exit their vehicle….
Retired HEAD OF FBI Tells ALL “Illuminati, Satanism …
http://www.youtube.com/watch?v=BplUD6kQYuU
Hi Sharon. I think the TDs are telling you that we probably should have at least a 4th thread – the Clubhouse one. How to link to it, I’m not sure. Ben?
Penny
#ClubHouse… #Politics, Religion, babble… Comment Link: https://www.stockgumshoe.com/2016/11/clubhouse-for-politics-religion-etc-volume-7/
#Travis Please initiate a Volume 8, as that one is getting long in the tooth. TIA
Love is blind; friendship closes its eyes. #Nietzsche
#Best2ALL!
Travis, Lynn Please start Vol. 8 …
https://www.stockgumshoe.com/2016/11/clubhouse-for-politics-religion-etc-volume-7/
Volume 8 has been created, here: https://www.stockgumshoe.com/2018/02/microblog-club-house-for-politics-religion-etc-volume-8/
Sharon – you probably thought you were on the ‘clubhouse thread’…….so many threads can get confusing and one has to scroll to the top or to the bottom to check……..sorry about the TD’s. Welcome back, good to have you here.!
LOL, sorry guys. I thought I was on that thread. I’ll blame it on old age, which ought to be good for something other than arthritis.
Utter Right Wing Nut Job nonsense. Breitbart is where you meant to post this crap? Maybe InfoWars!?! Bless your heart.
As I noted above, Analog, I did not mean to post that on this thread, and since its presence in the wrong place had to have been highly irritating, I’ll let you be insulting towards me this once. 🙂
Here is a link to the site for it, where opposable has given me something to mull over and I have responded to it.
https://www.stockgumshoe.com/2016/11/clubhouse-for-politics-religion-etc-volume-7/
Read the book “Classified Woman” by Sibel Edmonds, “Extreme prejudice” by Susan Lindauer and “Cover-up of convenience” by AshtonFerguson (The Lockerbie Cover up). The FBI is more corrupt than the crooks
twa14: Remember Edgar Hoover, a very conniving conservative head of FBI, he used many clandestine wiretaps, covert actions against people he did not like. It depends on who is in charge, but we need them to protect us against foreign intervention, criminals, and drug dealers.
Yes it is best to keep controversy off a stock site unless something is seen that may impact performance ie policy change by regulators, funding or such by Govt. & etc. (Amazon Care) IMO
WE need the Clubhouse for disagreement on other matters.
I think we may need to start another thread on which to bring new investment possibilities along with reason why they should be discussed.
Travis is very gracious in allowing such if anyone wants to moderate.
I am NOT a candidate. I am a bad investor in Bio. In fact, loser.
Those who want a committee or board,,, here is your chance.
ArchI totally agree. I’ve enjoyed the Sharon’s comments as well as the others regarding the FBI, etc., but I’m hoping with you that a we really need a thread regarding new investments and their merits or demerits that won’t conflict with whatever Doc is discussing. Thanks for putting that out there.
If anyone is interested, what Doc is putting out on Twitter would be of continuing interest to a lot of you
arch – your recent post (just above) is one of the most profound I have seen to date. The fact that Travis is willing to cooperate is cardinal and this concept would not be feasible without him. Although interested, I lack the credentials to take an active role. To remain an active bio-investor, I definitely require competent leadership.
I think it’s a fairly large crowd. And it includes myself. I think it was a hard task to come out positively.